AI Product
Owkin — Biotechnology
K Pro agentic AI platform and federated learning infrastructure connecting multimodal patient data with biological reasoning models for drug discovery, trial design, and diagnostics.
- Status
- Active
- Category
- Biotechnology
- Developer
- Owkin
- Industry
- AI in Healthcare
- Country
- France
Product Ecosystem Map
How this product connects across company, capabilities, technology, and markets on Brel.
Overview
What this product is, what it does, and who develops it.
Owkin — Biotechnology is an AI product from Owkin in the Biotechnology category.
K Pro agentic AI platform and federated learning infrastructure connecting multimodal patient data with biological reasoning models for drug discovery, trial design, and diagnostics.
It is designed for pharmaceutical and biotechnology companies, academic medical centers, and research hospitals participating in privacy-preserving data networks.
What it does
K Pro agentic AI platform and federated learning infrastructure connecting multimodal patient data with biological reasoning models for drug discovery, trial design, and diagnostics.
Who develops it
Pharmaceutical and biotechnology companies, academic medical centers, and research hospitals participating in privacy-preserving data networks.
Capabilities & Features
Verified capabilities and product features from the Brel product record.
Capabilities
- K Pro agentic AI platform and federated learning infrastructure connecting multimodal patient data with biological reasoning models for drug discovery, trial design, and diagnostics.
Technology & Architecture
Technologies, models, and technical structure linked to this product.
Technical operations in Owkin — Biotechnology rely on multi-tier machine learning architectures centered on Healthcare Analytics, Large Language Models, Agent, Machine Learning, Deep Learning, Predictive Analytics, Federated Learning, Medical Imaging, ensuring scalable computational performance. Further research on these computational systems is available in Brel's cornerstone coverage of Large Language Models, Machine Learning, Deep Learning.
Use Cases
Where this product is applied in real operational contexts.
- K Pro agentic AI platform and federated learning infrastructure connecting multimodal patient data with biological reasoning models for drug discovery, trial design, and diagnostics.
- Medical Imaging: Streamlining cross-functional collaboration and data handoffs.
- Ambient Scribing: Optimizing workflow execution latency and improving throughput.
- Workflow Automation: Eliminating manual data transcription and reducing operational errors.
Who It Is For
Target users, industries, and deployment context.
Pharmaceutical and biotechnology companies, academic medical centers, and research hospitals participating in privacy-preserving data networks.
Industries
Industries served
- AI in Healthcare
- Biotechnology
Serving technical teams, data leaders, and operational specialists in Healthcare, Owkin — Biotechnology combines operational speed with governance controls, supporting deployment environments such as air-gapped biomedical research clusters with encrypted enclaves.
Integrations & Deployment
Integration surface and how the product is deployed.
The platform supports modular integration through comprehensive developer documentation and structured REST endpoints. Organizations can embed Owkin — Biotechnology's intelligence directly into their existing internal dashboards.
Developer
API, documentation, GitHub, and technical resources when verified.
-
GitHub https://github.com/owkin
Developer / Company
The organization that builds and ships this product.
Maintained by Owkin in Paris, France established in 2016 by Thomas Clozel, Owkin — Biotechnology delivers automated intelligence capabilities designed specifically for Healthcare environments.
Recent Organizational Milestones: 2016: Owkin co-founded in Paris by Thomas Clozel, MD, and Gilles Wainrib, PhD. June 5, 2026: Owkin announced multi-year Sanofi collaboration to co-develop biopharma AI agents backed by a five-year K Pro license. May 13, 2026: Owkin announced multi-year K Pro license agreement with AstraZeneca.
Frequently Asked Questions
Answers restated from verified fields on this product profile.
What does Owkin — Biotechnology offer?
Owkin — Biotechnology is an AI solution developed by Owkin, designed to deliver elevating diagnostic accuracy and patient outcome reliability by systematizing evaluating multi-modal patient care metrics with statistical rigor.
What company operates Owkin — Biotechnology?
Owkin — Biotechnology is built and maintained by Owkin, based in Paris, France.
What are the main features of Owkin — Biotechnology?
Documented capabilities include: K Pro agentic AI platform and federated learning infrastructure connecting multimodal patient data with biological reasoning models for drug discovery, trial design, and diagnostics; Owkin's agentic AI stack — K Pro — deploys specialized biological agents for tasks such as target identification, drug positioning, pathology exploration, and literature synthesis; Federated learning lets models train across hospital silos with privacy controls, addressing a structural barrier in oncology and immunology datasets.
What algorithmic models drive Owkin — Biotechnology?
Owkin — Biotechnology utilizes Large Language Models, Agent, Machine Learning, Deep Learning, Predictive Analytics, Federated Learning, Medical Imaging, Healthcare Analytics, supporting deployment across air-gapped biomedical research clusters with encrypted enclaves.
Which organizations deploy Owkin — Biotechnology?
The software is engineered for Pharmaceutical and biotechnology companies, academic medical centers, and research hospitals participating in privacy-preserving data networks. seeking to mitigate patient biometric interpretation overhead and administrative reporting delays.
Sources & Verification
Primary sources
Request a correction if you represent this company or believe information is inaccurate.
Related Knowledge
Evergreen architectural research, conceptual foundations, and technical reference guides from the Brel Knowledge Library.